
News|Articles|August 1, 2025
Value reimagined: Unlocking ROI and efficiency in drug development
Author(s)Patheon
Trending on Pharmaceutical Technology
1
Triple-Negative Breast Cancer Deal Signals Oncology Licensing Shift
2
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
3
Is Organizational Readiness Pharma's Real AI Barrier in 2026?
4
How to Maintain a Productive Sponsor-CMO Relationship
5


